• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA对胶质母细胞瘤糖酵解代谢的调控

MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.

作者信息

Alfardus Huda, McIntyre Alan, Smith Stuart

机构信息

Children's Brain Tumour Research Centre, Queen's Medical Centre, D22 Medical School, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.

出版信息

Biomed Res Int. 2017;2017:9157370. doi: 10.1155/2017/9157370. Epub 2017 Jul 19.

DOI:10.1155/2017/9157370
PMID:28804724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539934/
Abstract

Glioblastoma (GBM) is the most aggressive and common malignant brain tumour in adults. A well-known hallmark of GMB and many other tumours is aerobic glycolysis. MicroRNAs (miRNAs) are a class of short nonprotein coding sequences that exert posttranscriptional controls on gene expression and represent critical regulators of aerobic glycolysis in GBM. In GBM, miRNAs regulate the expression of glycolytic genes directly and via the regulation of metabolism-associated tumour suppressors and oncogenic signalling pathways. This review aims to establish links between miRNAs expression levels, the expression of GBM glycolytic regulatory genes, and the malignant progression and prognosis of GBM. In this review, the involvement of 25 miRNAs in the regulation of glycolytic metabolism of GBM is discussed. Seven of these miRNAs have been shown to regulate glycolytic metabolism in other tumour types. Further eight miRNAs, which are differentially expressed in GBM, have also been reported to regulate glycolytic metabolism in other cancer types. Thus, these miRNAs could serve as potential glycolytic regulators in GBM but will require functional validation. As such, the characterisation of these molecular and metabolic signatures in GBM can facilitate a better understanding of the molecular pathogenesis of this disease.

摘要

胶质母细胞瘤(GBM)是成人中最具侵袭性且常见的恶性脑肿瘤。GBM以及许多其他肿瘤的一个众所周知的特征是有氧糖酵解。微小RNA(miRNA)是一类短的非蛋白质编码序列,可对基因表达进行转录后调控,并且是GBM中有氧糖酵解的关键调节因子。在GBM中,miRNA直接或通过调节与代谢相关的肿瘤抑制因子和致癌信号通路来调控糖酵解基因的表达。本综述旨在建立miRNA表达水平、GBM糖酵解调节基因的表达以及GBM的恶性进展和预后之间的联系。在本综述中,讨论了25种miRNA参与GBM糖酵解代谢调控的情况。其中7种miRNA已被证明可调节其他肿瘤类型的糖酵解代谢。另外8种在GBM中差异表达的miRNA,也已报道在其他癌症类型中调节糖酵解代谢。因此,这些miRNA可能是GBM潜在的糖酵解调节因子,但需要功能验证。同样,对GBM中这些分子和代谢特征的表征有助于更好地理解该疾病的分子发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/430bf3c3fe05/BMRI2017-9157370.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/def7ad3492d4/BMRI2017-9157370.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/b7f683672098/BMRI2017-9157370.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/a8f4b1588e94/BMRI2017-9157370.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/430bf3c3fe05/BMRI2017-9157370.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/def7ad3492d4/BMRI2017-9157370.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/b7f683672098/BMRI2017-9157370.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/a8f4b1588e94/BMRI2017-9157370.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39f/5539934/430bf3c3fe05/BMRI2017-9157370.004.jpg

相似文献

1
MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.微小RNA对胶质母细胞瘤糖酵解代谢的调控
Biomed Res Int. 2017;2017:9157370. doi: 10.1155/2017/9157370. Epub 2017 Jul 19.
2
MiR-21: A key player in glioblastoma pathogenesis.miR-21:胶质母细胞瘤发病机制中的关键分子。
J Cell Biochem. 2018 Feb;119(2):1285-1290. doi: 10.1002/jcb.26300. Epub 2017 Aug 28.
3
Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.异常表达的 microRNAs 调控胶质母细胞瘤的生物学特征。
Neuromolecular Med. 2018 Dec;20(4):452-474. doi: 10.1007/s12017-018-8507-9. Epub 2018 Sep 4.
4
Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.胶质母细胞瘤患者同步放化疗后 MicroRNAs 的差异表达。
OMICS. 2013 May;17(5):259-68. doi: 10.1089/omi.2012.0065. Epub 2013 Apr 15.
5
Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.蜂胶提取物调节脑胶质瘤和脑肿瘤干细胞中的 microRNA 表达。
Anticancer Agents Med Chem. 2022;22(2):378-389. doi: 10.2174/1871520621666210504082528.
6
Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.作为竞争性内源RNA参与多形性胶质母细胞瘤恶性进展的长链非编码RNA的鉴定及功能表征
Oncol Rep. 2016 Nov;36(5):2911-2925. doi: 10.3892/or.2016.5070. Epub 2016 Sep 5.
7
MicroRNAs involved in the EGFR pathway in glioblastoma.胶质母细胞瘤中涉及 EGFR 通路的 microRNAs。
Biomed Pharmacother. 2021 Feb;134:111115. doi: 10.1016/j.biopha.2020.111115. Epub 2020 Dec 16.
8
PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.NVP-BEZ235 抑制 PI3K 通路可抑制多形性胶质母细胞瘤细胞的糖酵解代谢。
Cells. 2021 Nov 7;10(11):3065. doi: 10.3390/cells10113065.
9
MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.《胶质母细胞瘤发病机制与治疗中的 microRNAs:全面综述》。
Crit Rev Oncol Hematol. 2017 Dec;120:22-33. doi: 10.1016/j.critrevonc.2017.10.003. Epub 2017 Oct 7.
10
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.缺氧诱导的miR-196a通过对NRAS的复杂调控来调节胶质母细胞瘤细胞的增殖和迁移。
Cell Oncol (Dordr). 2021 Apr;44(2):433-451. doi: 10.1007/s13402-020-00580-y. Epub 2021 Jan 19.

引用本文的文献

1
CCDC86-BHLHE40-ATF3 axis promotes aerobic glycolysis and tumor development in glioma.中国疾病预防控制中心86号蛋白-转录抑制因子40-活化转录因子3轴促进胶质瘤的有氧糖酵解和肿瘤发展。
Genes Dis. 2025 Apr 12;12(6):101643. doi: 10.1016/j.gendis.2025.101643. eCollection 2025 Nov.
2
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance.将胶质母细胞瘤中的代谢重编程作为克服治疗抗性的新策略。
Front Cell Dev Biol. 2025 Feb 26;13:1535073. doi: 10.3389/fcell.2025.1535073. eCollection 2025.
3
Central Nervous System Response Against Ionizing Radiation Exposure: Cellular, Biochemical, and Molecular Perspectives.

本文引用的文献

1
Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression.下调微小RNA-144通过调节葡萄糖转运蛋白1(GLUT1)的表达介导肺癌细胞的代谢转变。
Oncol Lett. 2016 Jun;11(6):3772-3776. doi: 10.3892/ol.2016.4468. Epub 2016 Apr 19.
2
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.微小RNA在多形性胶质母细胞瘤发病机制及治疗中的作用
Cancer Med. 2016 Aug;5(8):1917-46. doi: 10.1002/cam4.775. Epub 2016 Jun 10.
3
PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer.
中枢神经系统对电离辐射暴露的反应:细胞、生化和分子视角
Mol Neurobiol. 2025 Jun;62(6):7268-7295. doi: 10.1007/s12035-025-04712-z. Epub 2025 Jan 28.
4
Extracellular Vesicles Derived from Glioma Stem Cells Affect Glycometabolic Reprogramming of Glioma Cells Through the miR-10b-5p/PTEN/PI3K/Akt Pathway.外泌体来源于神经胶质瘤干细胞,通过 miR-10b-5p/PTEN/PI3K/Akt 通路影响神经胶质瘤细胞的糖代谢重编程。
Stem Cell Rev Rep. 2024 Apr;20(3):779-796. doi: 10.1007/s12015-024-10677-8. Epub 2024 Jan 31.
5
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma.miRNAs 及其在胶质母细胞瘤中的表观遗传效应的综合综述。
Cells. 2023 Jun 7;12(12):1578. doi: 10.3390/cells12121578.
6
Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer.三阴性乳腺癌中一种新型糖酵解相关预后风险特征的鉴定
Front Oncol. 2023 May 18;13:1171496. doi: 10.3389/fonc.2023.1171496. eCollection 2023.
7
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms.表观遗传学与代谢重编程在胶质母细胞瘤中的相互作用:免疫抑制机制的新见解
Antioxidants (Basel). 2023 Jan 18;12(2):220. doi: 10.3390/antiox12020220.
8
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.PRMT3 通过增强 HIF1A 和糖酵解代谢促进胶质母细胞瘤进展。
Cell Death Dis. 2022 Nov 9;13(11):943. doi: 10.1038/s41419-022-05389-1.
9
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.乳腺癌重编程中的代谢途径:非编码 RNA 的新视角。
Cells. 2022 Sep 23;11(19):2973. doi: 10.3390/cells11192973.
10
Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors.胶质瘤免疫微环境中的代谢重塑:与外周肿瘤不同的细胞间相互作用
Front Cell Dev Biol. 2021 Jun 11;9:693215. doi: 10.3389/fcell.2021.693215. eCollection 2021.
PFKL/miR-128轴通过抑制AKT磷酸化来调节糖酵解,并预示肺癌患者预后不良。
Am J Cancer Res. 2016 Jan 15;6(2):473-85. eCollection 2016.
4
miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.微小RNA-150-5p和微小RNA-133a通过靶向膜型-1基质金属蛋白酶抑制胶质瘤细胞的增殖和迁移。
Gene. 2016 Aug 10;587(2):155-62. doi: 10.1016/j.gene.2016.04.058. Epub 2016 May 3.
5
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.Myc驱动的糖酵解是胶质母细胞瘤的一个治疗靶点。
Clin Cancer Res. 2016 Sep 1;22(17):4452-65. doi: 10.1158/1078-0432.CCR-15-2274. Epub 2016 Apr 13.
6
miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.微小RNA-124通过抑制信号转导子和转录激活子3发挥胶质母细胞瘤肿瘤抑制因子的作用。
Mol Neurobiol. 2017 May;54(4):2555-2561. doi: 10.1007/s12035-016-9852-z. Epub 2016 Mar 18.
7
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.miR-34a-LDHA轴调节乳腺癌中的葡萄糖代谢和肿瘤生长。
Sci Rep. 2016 Feb 23;6:21735. doi: 10.1038/srep21735.
8
Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.靶向微小RNA-10b治疗已确诊的颅内胶质母细胞瘤的潜力:迈向临床的第一步
EMBO Mol Med. 2016 Mar 1;8(3):268-87. doi: 10.15252/emmm.201505495.
9
miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE.微小RNA-128通过靶向RhoE调节胶质瘤细胞的凋亡和增殖。
Oncol Lett. 2016 Jan;11(1):904-908. doi: 10.3892/ol.2015.3927. Epub 2015 Nov 17.
10
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.微小RNA-340可预测胶质母细胞瘤的生存期,并通过下调NRAS来调节关键的癌症特征。
Oncotarget. 2016 Apr 12;7(15):19531-47. doi: 10.18632/oncotarget.6968.